Yali Dou

16.0k citations
117 papers · 10.9k · 6 hit papers · h-index 48

Impact in

    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation
    • Genomics and Chromatin Dynamics
    • RNA modifications and cancer
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Ubiquitin and proteasome pathways
  • Aging top 1%

Papers in

    • Epigenetics and DNA Methylation 60
    • Genomics and Chromatin Dynamics 39
    • Cancer-related gene regulation 32
    • RNA modifications and cancer 24
    • Pluripotent Stem Cells Research 11
    • Protein Degradation and Inhibitors 10

Yali Dou

112 papers receiving 10.8k citations

Yali Dou's Hit Papers

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases 2015 · 452 citations
4520+7+14Years since publication250500750

Peers

Yali Dou
Comparison fields: 5 of 135
  • Molecular Biology 7.9k
  • Aging 160
  • Immunology 1.8k
  • Cancer Research 1.0k
  • Hematology 676
Replace Benjamin P.C. Chen with:
Benjamin P.C. Chen United States
Yue Lu United States
Suneet Agarwal United States
Tan A. Ince United States
Shinichi Saito Japan
John W. Tobias United States
Ralf Janknecht United States
Tarik Möröy Germany
Manuel Collado Spain
Gordon Peters United Kingdom
Yali Dou relative to Benjamin P.C. Chen United States Benjamin P.C. Chen's profile →
Citations per field
00.5×3.9×
Benjamin P.C. Chen · 1×
Citations per year

Countries citing papers authored by Yali Dou

Since Specialization
Citations

This map shows the geographic impact of Yali Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Dou more than expected).

Fields of papers citing papers by Yali Dou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yali Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Dou. The network helps show where Yali Dou may publish in the future.

Co-authors

The 25 scholars most cited alongside Yali Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yali Dou Line = papers co-authored together Yali Dou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Hit paper breakdown →
2015912
2
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Hit paper breakdown →
2004779
3
WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development
Hit paper breakdown →
2005645
4
Regulation of MLL1 H3K4 methyltransferase activity by its core components
Hit paper breakdown →
2006606
5
Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF
Hit paper breakdown →
2005536
6
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Hit paper breakdown →
2015452
7 2009386
8 2005353
9 2014302
10 2011268
11 2014238
12 2007237
13 2017219
14 2015214
15 2019186
16 2005178
17 2016175
18 2010164
19 2012159
20 2012149

About Yali Dou

Yali Dou is a scholar working on Molecular Biology, Cancer Research, Immunology, Hematology and Oncology, having authored 117 papers that have together received 10.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (60 papers), Genomics and Chromatin Dynamics (39 papers), Cancer-related gene regulation (32 papers), RNA modifications and cancer (24 papers), Pluripotent Stem Cells Research (11 papers), Protein Degradation and Inhibitors (10 papers), Immune Cell Function and Interaction (8 papers) and Acute Myeloid Leukemia Research (8 papers). The work is most often cited by research in Molecular Biology (7.9k citations), Aging (160 citations), Immunology (1.8k citations), Cancer Research (1.0k citations) and Hematology (676 citations). Yali Dou has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Robert G. Roeder, C. David Allis, Thomas A. Milne, Rajesh C. Rao, Joanna Wysocka, Jay L. Hess, Steven L. Kunkel, Martin A. Gorovsky, Lipeng Wu and Alexander J. Ruthenburg. Their work appears in journals such as Molecular Cell, Proceedings of the National Academy of Sciences, Nature Communications, Blood and Cell stem cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact